Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Biolidics Ltd. ( (SG:8YY) ).
Embracing Future Holdings Limited held its annual general meeting in Singapore on 29 April 2026, where shareholders adopted the audited financial statements for the year ended 31 December 2025 and approved directors’ fees of up to S$150,000 for the 2026 financial year. Shareholders also re-elected independent directors Ian David Brown and Liew Yoke Pheng Joseph, re-appointed PKF-CAP LLP as auditor, and granted the board authority to issue new shares and instruments, potentially up to 100% of the company’s issued share capital, enhancing the firm’s flexibility for future capital raising and corporate actions while maintaining compliance with SGX Catalist rules.
More about Biolidics Ltd.
Embracing Future Holdings Limited is a Singapore-incorporated company listed on the SGX Catalist board. It is governed by a board comprising executive and independent directors, with oversight from Audit, Nominating, and Remuneration Committees in line with Catalist corporate governance requirements.
Average Trading Volume: 5,741,487
Technical Sentiment Signal: Sell
Current Market Cap: S$78M
For a thorough assessment of 8YY stock, go to TipRanks’ Stock Analysis page.